IntroductionMast cells are the major effector cell type in immunoglobulin E (IgE)-mediated immediate hypersensitivity, chronic allergic diseases, and the defense against certain parasites and bacteria. Traditionally, it is thought that mast cells bound to antigen-specific IgE via the high-affinity receptor (Fc⑀RI) encounter multivalent antigen (the stimulation mode hereafter termed IgEϩAg), and then IgE-bound receptors are aggregated, leading to cellular activation. 1 Activated mast cells secrete preformed and newly synthesized proinflammatory mediators, such as histamine, proteases, lipids, cytokines, and chemokines.The mouse Fc⑀RI consists of an IgE-binding ␣ subunit, a  subunit, and 2 molecules of signal-generating ␥ subunit. 2 Fc⑀RI aggregation leads to phosphorylation of the immunoreceptor tyrosine-based activation motifs (ITAMs) of the  and ␥ subunits by Lyn, and recruitment of Syk to the tyrosine-phosphorylated ITAMs of the ␥ subunit results in the activation of this proteintyrosine kinase (PTK). 3 Activated Lyn and Syk as well as Fyn eventually lead to the activation of multiple signaling pathways, including phosphatidylinositol 3-kinase (PI3K), phospholipase C-␥/Ca 2ϩ /protein kinase C (PKC), and mitogen-activated protein (MAP) kinases. 4 Cell-extracellular matrix interactions mediated by integrins play a critical role in multiple cellular functions including cell adhesion and migration. Activation of mast cells by Fc⑀RI aggregation and stem cell factor (SCF) induces adhesion to fibronectin (FN) 5 predominantly via integrin ␣51. 6-8 Upon Fc⑀RI aggregation and SCF stimulation, FN-adherent cells exhibit stronger effector functions such as histamine release and cytokine production than nonadherent cells. 7 We and others recently demonstrated that monomeric IgE can promote mast cell survival. 9,10 This observation, together with earlier studies showing that IgE in the absence of antigen can increase the surface expression of Fc⑀RI, [11][12][13] has transformed the traditional view of IgE-mast cell binding as a "sensitization" step prior to receptor aggregation with antigen or other crosslinking reagents into a new one that monomeric IgE can induce survival and "activation" of mast cells. 14 We also found that IgE molecules display heterogeneity in that different IgE molecules induce varied levels of activation; at one extreme end of the spectrum, some IgE molecules, termed highly cytokinergic (HC) IgEs, induce the production and secretion of various cytokines and other activation events including degranulation, whereas other IgE molecules, termed poorly cytokinergic (PC), do so very inefficiently. 15 Mast cells accumulate at local inflammatory mucosal tissues, as seen in allergic rhinitis and asthma. Interestingly, class switch recombination and somatic hypermutation of the immunoglobulin gene and eventually IgE synthesis and secretion occur at such inflammatory mucosae. [16][17][18][19][20][21] In an allergic individual, local IgE production persists for a long period in the absence of allergen. 20 A va...